Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Semin Ophthalmol ; 33(1): 126-133, 2018.
Article in English | MEDLINE | ID: mdl-29215958

ABSTRACT

Despite recent advances in the medical management of diabetic retinal disease, there remain established indications for vitreoretinal surgery in the treatment of severe proliferative diabetic retinopathy. These include non-clearing vitreous hemorrhage and tractional retinal detachment. Advances in surgical instrumentation, technique, and experience have led to improved visual outcomes, as well as a corresponding decrease in the incidence of postoperative complications. However, the presence of systemic and ocular factors in diabetic patients increases the risk of adverse events compared to non-diabetic individuals. This review will focus on the most important postoperative complications following pars plana vitrectomy, with specific considerations for the diabetic patient.


Subject(s)
Diabetic Retinopathy/surgery , Postoperative Complications , Vitrectomy/adverse effects , Humans , Visual Acuity
2.
Retina ; 34(10): 1960-8, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24830822

ABSTRACT

PURPOSE: To compare visual acuity outcomes and diabetic retinopathy progression after pars plana vitrectomy (PPV) versus combined pars plana vitrectomy and phacoemulsification (PPVCE) in patients with diabetes. METHODS: Retrospective review of 222 consecutive diabetic patients undergoing PPV or PPVCE. RESULTS: A total of 251 eyes of 222 patients were evaluated (PPV = 122, PPVCE = 129). Four-year follow-up was 64% (161 eyes). Overall, patients undergoing PPVCE had better preoperative visual acuity (PPVCE = 20/80, PPV = 20/160, P = 0.03). At 4-year follow-up, visual acuity improved (PPV = +22, PPVCE = +11 letters) compared with baseline in both groups. After correcting for baseline differences in visual acuity, no statistically significant difference in final visual acuity was observed (PPVCE = 20/32, PPV = 20/50, P = 0.09). Results did not differ substantially by surgical indication (vitreous hemorrhage, traction retinal detachment, epiretinal membrane, and/or diabetic macular edema). Cataract progression occurred in 64%, and cataract surgery was performed in 39% of phakic eyes undergoing PPV. Rates of diabetic retinopathy progression, vitreous hemorrhage, and retinal detachment were not statistically different. Neovascular glaucoma developed in 2 patients (2%) after PPV and 6 patients (8%) after PPVCE (P = 0.07). CONCLUSION: In diabetic patients, equivalent visual acuity improvement over 4 years was observed after PPV or PPVCE. Visual outcomes and retinopathy progression rates were not significantly different after either intervention, suggesting that PPVCE may be appropriate when indicated in patients with diabetes.


Subject(s)
Diabetic Retinopathy/surgery , Lens Implantation, Intraocular , Phacoemulsification , Visual Acuity/physiology , Vitrectomy , Adult , Aged , Aged, 80 and over , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/physiopathology , Disease Progression , Female , Humans , Male , Middle Aged , Pseudophakia/physiopathology , Retrospective Studies , Tomography, Optical Coherence
3.
Retina ; 30(9): 1488-95, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20924264

ABSTRACT

PURPOSE: To evaluate factors ¶associated with favorable outcomes after vitrectomy for diabetic macular edema. METHODS: Data were collected prospectively on 241 eyes undergoing vitrectomy for diabetic macular edema. Multivariate models were used to evaluate associations of 20 preoperative and intraoperative factors with 6-month outcomes of visual acuity and retinal thickness. RESULTS: Median central subfield thickness decreased from 412 µm to 278 µm at 6 months, but median visual acuity remained unchanged (20/80, Snellen equivalent). Greater visual acuity improvement occurred in eyes with worse baseline acuity (P < 0.001) and in eyes in which an epiretinal membrane was removed (P = 0.006). Greater reduction in central subfield thickness occurred with worse baseline visual acuity (P < 0.001), greater preoperative retinal thickness (P = 0.001), removal of internal limiting membrane (P = 0.003), and optical coherence tomography evidence of vitreoretinal abnormalities (P = 0.006). No associations with clinician's preoperative assessments of the posterior vitreous were identified. CONCLUSION: These results suggest that the removal of epiretinal membranes may favorably affect visual outcome after vitrectomy. Preoperative presence of vitreoretinal abnormalities appeared to be associated with somewhat greater reductions in retinal thickness but not with visual acuity outcome. These results may be useful for future studies evaluating vitrectomy for diabetic macular edema.


Subject(s)
Diabetic Retinopathy/physiopathology , Diabetic Retinopathy/surgery , Macular Edema/physiopathology , Macular Edema/surgery , Visual Acuity/physiology , Vitrectomy , Adult , Aged , Aged, 80 and over , Basement Membrane , Epiretinal Membrane/physiopathology , Epiretinal Membrane/surgery , Female , Humans , Intraoperative Complications , Male , Middle Aged , Prospective Studies , Retina/pathology , Risk Factors , Tomography, Optical Coherence , Treatment Outcome
4.
Nat Med ; 13(2): 181-8, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17259996

ABSTRACT

Excessive retinal vascular permeability contributes to the pathogenesis of proliferative diabetic retinopathy and diabetic macular edema, leading causes of vision loss in working-age adults. Using mass spectroscopy-based proteomics, we detected 117 proteins in human vitreous and elevated levels of extracellular carbonic anhydrase-I (CA-I) in vitreous from individuals with diabetic retinopathy, suggesting that retinal hemorrhage and erythrocyte lysis contribute to the diabetic vitreous proteome. Intravitreous injection of CA-I in rats increased retinal vessel leakage and caused intraretinal edema. CA-I-induced alkalinization of vitreous increased kallikrein activity and its generation of factor XIIa, revealing a new pathway for contact system activation. CA-I-induced retinal edema was decreased by complement 1 inhibitor, neutralizing antibody to prekallikrein and bradykinin receptor antagonism. Subdural infusion of CA-I in rats induced cerebral vascular permeability, suggesting that extracellular CA-I could have broad relevance to neurovascular edema. Inhibition of extracellular CA-I and kallikrein-mediated innate inflammation could provide new therapeutic opportunities for the treatment of hemorrhage-induced retinal and cerebral edema.


Subject(s)
Capillary Permeability/drug effects , Carbonic Anhydrase Inhibitors/therapeutic use , Carbonic Anhydrases/metabolism , Diabetic Retinopathy/drug therapy , Eye Proteins/metabolism , Kallikrein-Kinin System/physiology , Vitreous Body/enzymology , Acetazolamide/pharmacology , Animals , Blotting, Western , Bradykinin Receptor Antagonists , Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrases/toxicity , Complement C1/antagonists & inhibitors , Factor XIIa/metabolism , Humans , Mass Spectrometry , Papilledema/chemically induced , Proteomics , Rats , Rats, Sprague-Dawley , Statistics, Nonparametric
5.
Am J Ophthalmol ; 139(4): 719-21, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15808176

ABSTRACT

PURPOSE: To report acute unilateral hypopyon uveitis as an initial presenting feature of relapsing acute lymphoblastic leukemia (ALL) in an adult patient. DESIGN: Observational case report. METHODS: Anterior chamber paracentesis was performed in a 56-year-old male presenting with treatment-resistant unilateral hypopyon while in the remission phase of ALL. RESULTS: Examination of the aqueous humor aspirate revealed presence of malignant cells compatible with the previous bone marrow biopsy and subsequent spinal tap results. CONCLUSIONS: Atypical hypopyon uveitis can be an indication of relapsing ALL, even in adults. Prompt anterior chamber aspiration is required for the correct diagnosis and subsequent treatment.


Subject(s)
Anterior Chamber/pathology , Eye Neoplasms/diagnosis , Neoplasm Recurrence, Local/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Uveitis, Anterior/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Aqueous Humor/cytology , Bone Marrow Cells/pathology , Cerebrospinal Fluid/cytology , Eye Neoplasms/drug therapy , Eye Neoplasms/genetics , Glaucoma/diagnosis , Humans , Intraocular Pressure , Leukemic Infiltration , Male , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Suppuration/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...